nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2D6—breast cancer	0.14	0.538	CbGaD
Fingolimod—CYP3A4—breast cancer	0.12	0.462	CbGaD
Fingolimod—CYP3A4—Exemestane—breast cancer	0.0261	0.088	CbGbCtD
Fingolimod—CYP2D6—Idarubicin—breast cancer	0.0235	0.0795	CbGbCtD
Fingolimod—CYP3A4—Letrozole—breast cancer	0.0222	0.0748	CbGbCtD
Fingolimod—CYP2E1—Tamoxifen—breast cancer	0.0218	0.0736	CbGbCtD
Fingolimod—CYP2E1—Mitoxantrone—breast cancer	0.0212	0.0717	CbGbCtD
Fingolimod—CYP3A4—Anastrozole—breast cancer	0.0197	0.0667	CbGbCtD
Fingolimod—CYP3A4—Toremifene—breast cancer	0.0181	0.061	CbGbCtD
Fingolimod—CYP3A4—Fulvestrant—breast cancer	0.0168	0.0567	CbGbCtD
Fingolimod—CYP3A4—Thiotepa—breast cancer	0.015	0.0506	CbGbCtD
Fingolimod—CYP3A4—Ixabepilone—breast cancer	0.0137	0.0462	CbGbCtD
Fingolimod—CYP3A4—Lapatinib—breast cancer	0.0132	0.0445	CbGbCtD
Fingolimod—CYP2D6—Vinorelbine—breast cancer	0.0115	0.0388	CbGbCtD
Fingolimod—CYP2D6—Tamoxifen—breast cancer	0.0104	0.0351	CbGbCtD
Fingolimod—CYP3A4—Raloxifene—breast cancer	0.00999	0.0337	CbGbCtD
Fingolimod—S1PR1—umbilical vein—breast cancer	0.00955	0.0938	CbGeAlD
Fingolimod—CYP3A4—Vinorelbine—breast cancer	0.00731	0.0247	CbGbCtD
Fingolimod—CYP2D6—Vinblastine—breast cancer	0.00708	0.0239	CbGbCtD
Fingolimod—CYP3A4—Tamoxifen—breast cancer	0.0066	0.0223	CbGbCtD
Fingolimod—CYP3A4—Mitoxantrone—breast cancer	0.00644	0.0217	CbGbCtD
Fingolimod—CYP3A4—Paclitaxel—breast cancer	0.00514	0.0173	CbGbCtD
Fingolimod—CYP3A4—Irinotecan—breast cancer	0.00507	0.0171	CbGbCtD
Fingolimod—S1PR5—mammary gland—breast cancer	0.00498	0.0489	CbGeAlD
Fingolimod—CYP3A4—Vinblastine—breast cancer	0.0045	0.0152	CbGbCtD
Fingolimod—CYP2D6—Doxorubicin—breast cancer	0.00435	0.0147	CbGbCtD
Fingolimod—CYP3A4—Docetaxel—breast cancer	0.00371	0.0125	CbGbCtD
Fingolimod—S1PR1—mammary gland—breast cancer	0.00365	0.0359	CbGeAlD
Fingolimod—SPHK1—mammary gland—breast cancer	0.00361	0.0355	CbGeAlD
Fingolimod—SPHK1—nipple—breast cancer	0.00299	0.0293	CbGeAlD
Fingolimod—CYP4F12—nipple—breast cancer	0.00287	0.0282	CbGeAlD
Fingolimod—CYP3A4—Doxorubicin—breast cancer	0.00277	0.00935	CbGbCtD
Fingolimod—S1PR4—adipose tissue—breast cancer	0.00267	0.0262	CbGeAlD
Fingolimod—S1PR5—skin of body—breast cancer	0.00264	0.0259	CbGeAlD
Fingolimod—S1PR4—adrenal gland—breast cancer	0.00239	0.0235	CbGeAlD
Fingolimod—S1PR4—bone marrow—breast cancer	0.00232	0.0227	CbGeAlD
Fingolimod—S1PR4—endocrine gland—breast cancer	0.00208	0.0204	CbGeAlD
Fingolimod—S1PR5—female reproductive system—breast cancer	0.00206	0.0202	CbGeAlD
Fingolimod—S1PR1—epithelium—breast cancer	0.00203	0.02	CbGeAlD
Fingolimod—S1PR5—adrenal gland—breast cancer	0.00201	0.0198	CbGeAlD
Fingolimod—SPHK1—skin of body—breast cancer	0.00191	0.0188	CbGeAlD
Fingolimod—S1PR3—adipose tissue—breast cancer	0.00186	0.0183	CbGeAlD
Fingolimod—CYP4F2—bone marrow—breast cancer	0.00182	0.0179	CbGeAlD
Fingolimod—SPHK1—endometrium—breast cancer	0.0018	0.0177	CbGeAlD
Fingolimod—S1PR5—endocrine gland—breast cancer	0.00174	0.0171	CbGeAlD
Fingolimod—CYP4F12—endometrium—breast cancer	0.00173	0.017	CbGeAlD
Fingolimod—S1PR3—female reproductive system—breast cancer	0.00171	0.0168	CbGeAlD
Fingolimod—S1PR3—adrenal gland—breast cancer	0.00167	0.0164	CbGeAlD
Fingolimod—SPHK1—uterus—breast cancer	0.00166	0.0163	CbGeAlD
Fingolimod—S1PR1—adipose tissue—breast cancer	0.00164	0.0161	CbGeAlD
Fingolimod—CYP4F2—endocrine gland—breast cancer	0.00163	0.0161	CbGeAlD
Fingolimod—SPHK1—pituitary gland—breast cancer	0.00163	0.016	CbGeAlD
Fingolimod—SPHK1—adipose tissue—breast cancer	0.00163	0.016	CbGeAlD
Fingolimod—CYP4F12—uterus—breast cancer	0.0016	0.0157	CbGeAlD
Fingolimod—CYP4F12—pituitary gland—breast cancer	0.00157	0.0154	CbGeAlD
Fingolimod—CYP4F12—adipose tissue—breast cancer	0.00156	0.0153	CbGeAlD
Fingolimod—S1PR3—female gonad—breast cancer	0.00156	0.0153	CbGeAlD
Fingolimod—S1PR1—female reproductive system—breast cancer	0.00151	0.0148	CbGeAlD
Fingolimod—SPHK1—female reproductive system—breast cancer	0.00149	0.0147	CbGeAlD
Fingolimod—S1PR1—adrenal gland—breast cancer	0.00147	0.0145	CbGeAlD
Fingolimod—SPHK1—adrenal gland—breast cancer	0.00146	0.0143	CbGeAlD
Fingolimod—S1PR3—endocrine gland—breast cancer	0.00145	0.0142	CbGeAlD
Fingolimod—CYP4F12—female reproductive system—breast cancer	0.00144	0.0141	CbGeAlD
Fingolimod—S1PR4—lymph node—breast cancer	0.00143	0.0141	CbGeAlD
Fingolimod—CYP4F12—adrenal gland—breast cancer	0.0014	0.0138	CbGeAlD
Fingolimod—SPHK1—Dexamethasone—Fluoxymesterone—breast cancer	0.00138	0.5	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Fluoxymesterone—breast cancer	0.00138	0.5	CbGdCrCtD
Fingolimod—S1PR1—female gonad—breast cancer	0.00137	0.0135	CbGeAlD
Fingolimod—SPHK1—female gonad—breast cancer	0.00136	0.0134	CbGeAlD
Fingolimod—CYP4F12—bone marrow—breast cancer	0.00135	0.0133	CbGeAlD
Fingolimod—CYP4F12—female gonad—breast cancer	0.00131	0.0128	CbGeAlD
Fingolimod—S1PR1—endocrine gland—breast cancer	0.00128	0.0126	CbGeAlD
Fingolimod—SPHK1—endocrine gland—breast cancer	0.00126	0.0124	CbGeAlD
Fingolimod—CYP4F12—endocrine gland—breast cancer	0.00121	0.0119	CbGeAlD
Fingolimod—S1PR5—lymph node—breast cancer	0.00121	0.0118	CbGeAlD
Fingolimod—S1PR3—lymph node—breast cancer	0.001	0.00984	CbGeAlD
Fingolimod—S1PR1—lymph node—breast cancer	0.000883	0.00868	CbGeAlD
Fingolimod—SPHK1—lymph node—breast cancer	0.000874	0.00858	CbGeAlD
Fingolimod—CYP4F12—lymph node—breast cancer	0.00084	0.00825	CbGeAlD
Fingolimod—CYP2E1—female reproductive system—breast cancer	0.000242	0.00238	CbGeAlD
Fingolimod—CYP2E1—adrenal gland—breast cancer	0.000236	0.00232	CbGeAlD
Fingolimod—CYP2E1—endocrine gland—breast cancer	0.000205	0.00201	CbGeAlD
Fingolimod—CYP3A4—female reproductive system—breast cancer	0.000195	0.00191	CbGeAlD
Fingolimod—CYP2D6—female reproductive system—breast cancer	0.000192	0.00188	CbGeAlD
Fingolimod—CYP2D6—female gonad—breast cancer	0.000174	0.00171	CbGeAlD
Fingolimod—CYP3A4—endocrine gland—breast cancer	0.000165	0.00162	CbGeAlD
Fingolimod—CYP2D6—endocrine gland—breast cancer	0.000162	0.00159	CbGeAlD
Fingolimod—Infection—Irinotecan—breast cancer	0.000106	0.000674	CcSEcCtD
Fingolimod—Pruritus—Melphalan—breast cancer	0.000105	0.000667	CcSEcCtD
Fingolimod—Nervous system disorder—Irinotecan—breast cancer	0.000105	0.000666	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—breast cancer	0.000105	0.000663	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—breast cancer	0.000104	0.00066	CcSEcCtD
Fingolimod—Asthenia—Goserelin—breast cancer	0.000104	0.000659	CcSEcCtD
Fingolimod—Skin disorder—Mitoxantrone—breast cancer	0.000104	0.000659	CcSEcCtD
Fingolimod—Diarrhoea—Tamoxifen—breast cancer	0.000104	0.000658	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—breast cancer	0.000104	0.000657	CcSEcCtD
Fingolimod—Infection—Gemcitabine—breast cancer	0.000104	0.000657	CcSEcCtD
Fingolimod—Back pain—Paclitaxel—breast cancer	0.000104	0.000656	CcSEcCtD
Fingolimod—Dizziness—Vinblastine—breast cancer	0.000103	0.000655	CcSEcCtD
Fingolimod—Bradycardia—Capecitabine—breast cancer	0.000103	0.000651	CcSEcCtD
Fingolimod—Pruritus—Goserelin—breast cancer	0.000103	0.00065	CcSEcCtD
Fingolimod—Connective tissue disorder—Docetaxel—breast cancer	0.000102	0.000649	CcSEcCtD
Fingolimod—Nervous system disorder—Gemcitabine—breast cancer	0.000102	0.000648	CcSEcCtD
Fingolimod—Infection—Fluorouracil—breast cancer	0.000102	0.000646	CcSEcCtD
Fingolimod—Diarrhoea—Melphalan—breast cancer	0.000102	0.000645	CcSEcCtD
Fingolimod—Skin disorder—Gemcitabine—breast cancer	0.000101	0.000642	CcSEcCtD
Fingolimod—Vision blurred—Paclitaxel—breast cancer	0.000101	0.000639	CcSEcCtD
Fingolimod—Nervous system disorder—Fluorouracil—breast cancer	0.000101	0.000638	CcSEcCtD
Fingolimod—Dizziness—Tamoxifen—breast cancer	0.0001	0.000636	CcSEcCtD
Fingolimod—Liver function test abnormal—Methotrexate—breast cancer	0.0001	0.000635	CcSEcCtD
Fingolimod—Hypotension—Mitoxantrone—breast cancer	0.0001	0.000634	CcSEcCtD
Fingolimod—Hypotension—Irinotecan—breast cancer	0.0001	0.000634	CcSEcCtD
Fingolimod—Migraine—Epirubicin—breast cancer	0.0001	0.000634	CcSEcCtD
Fingolimod—Diarrhoea—Goserelin—breast cancer	9.93e-05	0.000629	CcSEcCtD
Fingolimod—Connective tissue disorder—Capecitabine—breast cancer	9.92e-05	0.000628	CcSEcCtD
Fingolimod—Headache—Vinblastine—breast cancer	9.8e-05	0.00062	CcSEcCtD
Fingolimod—Hypotension—Gemcitabine—breast cancer	9.76e-05	0.000618	CcSEcCtD
Fingolimod—Eye disorder—Docetaxel—breast cancer	9.75e-05	0.000617	CcSEcCtD
Fingolimod—Cardiac disorder—Docetaxel—breast cancer	9.68e-05	0.000613	CcSEcCtD
Fingolimod—Cardiac arrest—Epirubicin—breast cancer	9.67e-05	0.000612	CcSEcCtD
Fingolimod—Paraesthesia—Mitoxantrone—breast cancer	9.62e-05	0.00061	CcSEcCtD
Fingolimod—Paraesthesia—Irinotecan—breast cancer	9.62e-05	0.00061	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—breast cancer	9.6e-05	0.000608	CcSEcCtD
Fingolimod—Dizziness—Goserelin—breast cancer	9.6e-05	0.000608	CcSEcCtD
Fingolimod—Hypotension—Fluorouracil—breast cancer	9.59e-05	0.000607	CcSEcCtD
Fingolimod—Leukopenia—Paclitaxel—breast cancer	9.59e-05	0.000607	CcSEcCtD
Fingolimod—Dyspnoea—Mitoxantrone—breast cancer	9.56e-05	0.000605	CcSEcCtD
Fingolimod—Dyspnoea—Irinotecan—breast cancer	9.56e-05	0.000605	CcSEcCtD
Fingolimod—Headache—Tamoxifen—breast cancer	9.52e-05	0.000603	CcSEcCtD
Fingolimod—Palpitations—Paclitaxel—breast cancer	9.47e-05	0.000599	CcSEcCtD
Fingolimod—Angiopathy—Docetaxel—breast cancer	9.46e-05	0.000599	CcSEcCtD
Fingolimod—Eye disorder—Capecitabine—breast cancer	9.44e-05	0.000598	CcSEcCtD
Fingolimod—Mediastinal disorder—Docetaxel—breast cancer	9.4e-05	0.000595	CcSEcCtD
Fingolimod—Liver function test abnormal—Epirubicin—breast cancer	9.39e-05	0.000595	CcSEcCtD
Fingolimod—Paraesthesia—Gemcitabine—breast cancer	9.38e-05	0.000594	CcSEcCtD
Fingolimod—Cardiac disorder—Capecitabine—breast cancer	9.37e-05	0.000593	CcSEcCtD
Fingolimod—Cough—Paclitaxel—breast cancer	9.35e-05	0.000592	CcSEcCtD
Fingolimod—Asthenia—Vinorelbine—breast cancer	9.32e-05	0.000591	CcSEcCtD
Fingolimod—Dyspnoea—Gemcitabine—breast cancer	9.31e-05	0.000589	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—breast cancer	9.26e-05	0.000586	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Irinotecan—breast cancer	9.25e-05	0.000586	CcSEcCtD
Fingolimod—Hypertension—Paclitaxel—breast cancer	9.25e-05	0.000586	CcSEcCtD
Fingolimod—Fatigue—Irinotecan—breast cancer	9.24e-05	0.000585	CcSEcCtD
Fingolimod—Fatigue—Mitoxantrone—breast cancer	9.24e-05	0.000585	CcSEcCtD
Fingolimod—Paraesthesia—Fluorouracil—breast cancer	9.22e-05	0.000584	CcSEcCtD
Fingolimod—Alopecia—Docetaxel—breast cancer	9.22e-05	0.000584	CcSEcCtD
Fingolimod—Pruritus—Vinorelbine—breast cancer	9.19e-05	0.000582	CcSEcCtD
Fingolimod—Angiopathy—Capecitabine—breast cancer	9.16e-05	0.00058	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—breast cancer	9.16e-05	0.00058	CcSEcCtD
Fingolimod—Dyspnoea—Fluorouracil—breast cancer	9.15e-05	0.00058	CcSEcCtD
Fingolimod—Mental disorder—Docetaxel—breast cancer	9.14e-05	0.000579	CcSEcCtD
Fingolimod—Mediastinal disorder—Capecitabine—breast cancer	9.1e-05	0.000576	CcSEcCtD
Fingolimod—Headache—Goserelin—breast cancer	9.09e-05	0.000576	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	9.06e-05	0.000574	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Gemcitabine—breast cancer	9.01e-05	0.000571	CcSEcCtD
Fingolimod—Fatigue—Gemcitabine—breast cancer	9e-05	0.00057	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Epirubicin—breast cancer	8.97e-05	0.000568	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—breast cancer	8.95e-05	0.000567	CcSEcCtD
Fingolimod—Alopecia—Capecitabine—breast cancer	8.92e-05	0.000565	CcSEcCtD
Fingolimod—Asthenia—Thiotepa—breast cancer	8.91e-05	0.000564	CcSEcCtD
Fingolimod—Diarrhoea—Vinorelbine—breast cancer	8.89e-05	0.000563	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Fluorouracil—breast cancer	8.86e-05	0.000561	CcSEcCtD
Fingolimod—Mental disorder—Capecitabine—breast cancer	8.85e-05	0.00056	CcSEcCtD
Fingolimod—Influenza—Epirubicin—breast cancer	8.79e-05	0.000557	CcSEcCtD
Fingolimod—Back pain—Docetaxel—breast cancer	8.78e-05	0.000556	CcSEcCtD
Fingolimod—Pruritus—Thiotepa—breast cancer	8.78e-05	0.000556	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—breast cancer	8.69e-05	0.00055	CcSEcCtD
Fingolimod—Infection—Paclitaxel—breast cancer	8.68e-05	0.00055	CcSEcCtD
Fingolimod—Dizziness—Vinorelbine—breast cancer	8.59e-05	0.000544	CcSEcCtD
Fingolimod—Nervous system disorder—Paclitaxel—breast cancer	8.57e-05	0.000543	CcSEcCtD
Fingolimod—Back pain—Capecitabine—breast cancer	8.5e-05	0.000538	CcSEcCtD
Fingolimod—Diarrhoea—Thiotepa—breast cancer	8.49e-05	0.000538	CcSEcCtD
Fingolimod—Skin disorder—Paclitaxel—breast cancer	8.49e-05	0.000538	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—breast cancer	8.47e-05	0.000537	CcSEcCtD
Fingolimod—Bronchitis—Epirubicin—breast cancer	8.45e-05	0.000535	CcSEcCtD
Fingolimod—Pneumonia—Methotrexate—breast cancer	8.42e-05	0.000533	CcSEcCtD
Fingolimod—Infestation—Methotrexate—breast cancer	8.37e-05	0.00053	CcSEcCtD
Fingolimod—Infestation NOS—Methotrexate—breast cancer	8.37e-05	0.00053	CcSEcCtD
Fingolimod—Depression—Methotrexate—breast cancer	8.35e-05	0.000529	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—breast cancer	8.3e-05	0.000525	CcSEcCtD
Fingolimod—Vision blurred—Capecitabine—breast cancer	8.28e-05	0.000525	CcSEcCtD
Fingolimod—Dizziness—Thiotepa—breast cancer	8.21e-05	0.00052	CcSEcCtD
Fingolimod—Hypotension—Paclitaxel—breast cancer	8.17e-05	0.000517	CcSEcCtD
Fingolimod—Headache—Vinorelbine—breast cancer	8.14e-05	0.000516	CcSEcCtD
Fingolimod—Influenza—Doxorubicin—breast cancer	8.13e-05	0.000515	CcSEcCtD
Fingolimod—Leukopenia—Docetaxel—breast cancer	8.13e-05	0.000515	CcSEcCtD
Fingolimod—Palpitations—Docetaxel—breast cancer	8.02e-05	0.000508	CcSEcCtD
Fingolimod—Weight decreased—Epirubicin—breast cancer	7.95e-05	0.000504	CcSEcCtD
Fingolimod—Cough—Docetaxel—breast cancer	7.92e-05	0.000502	CcSEcCtD
Fingolimod—Pneumonia—Epirubicin—breast cancer	7.88e-05	0.000499	CcSEcCtD
Fingolimod—Leukopenia—Capecitabine—breast cancer	7.87e-05	0.000498	CcSEcCtD
Fingolimod—Paraesthesia—Paclitaxel—breast cancer	7.85e-05	0.000497	CcSEcCtD
Fingolimod—Hypertension—Docetaxel—breast cancer	7.84e-05	0.000496	CcSEcCtD
Fingolimod—Infestation NOS—Epirubicin—breast cancer	7.84e-05	0.000496	CcSEcCtD
Fingolimod—Infestation—Epirubicin—breast cancer	7.84e-05	0.000496	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—breast cancer	7.82e-05	0.000495	CcSEcCtD
Fingolimod—Dyspnoea—Paclitaxel—breast cancer	7.79e-05	0.000494	CcSEcCtD
Fingolimod—Headache—Thiotepa—breast cancer	7.78e-05	0.000492	CcSEcCtD
Fingolimod—Palpitations—Capecitabine—breast cancer	7.77e-05	0.000492	CcSEcCtD
Fingolimod—Asthenia—Irinotecan—breast cancer	7.69e-05	0.000487	CcSEcCtD
Fingolimod—Asthenia—Mitoxantrone—breast cancer	7.69e-05	0.000487	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	7.68e-05	0.000486	CcSEcCtD
Fingolimod—Cough—Capecitabine—breast cancer	7.67e-05	0.000486	CcSEcCtD
Fingolimod—Hypertension—Capecitabine—breast cancer	7.59e-05	0.000481	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Paclitaxel—breast cancer	7.55e-05	0.000478	CcSEcCtD
Fingolimod—Fatigue—Paclitaxel—breast cancer	7.54e-05	0.000477	CcSEcCtD
Fingolimod—Asthenia—Gemcitabine—breast cancer	7.49e-05	0.000474	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	7.43e-05	0.000471	CcSEcCtD
Fingolimod—Pruritus—Gemcitabine—breast cancer	7.39e-05	0.000468	CcSEcCtD
Fingolimod—Infection—Docetaxel—breast cancer	7.36e-05	0.000466	CcSEcCtD
Fingolimod—Weight decreased—Doxorubicin—breast cancer	7.36e-05	0.000466	CcSEcCtD
Fingolimod—Sinusitis—Epirubicin—breast cancer	7.35e-05	0.000466	CcSEcCtD
Fingolimod—Diarrhoea—Mitoxantrone—breast cancer	7.33e-05	0.000464	CcSEcCtD
Fingolimod—Diarrhoea—Irinotecan—breast cancer	7.33e-05	0.000464	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—breast cancer	7.29e-05	0.000462	CcSEcCtD
Fingolimod—Nervous system disorder—Docetaxel—breast cancer	7.27e-05	0.00046	CcSEcCtD
Fingolimod—Pruritus—Fluorouracil—breast cancer	7.26e-05	0.00046	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—breast cancer	7.25e-05	0.000459	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—breast cancer	7.25e-05	0.000459	CcSEcCtD
Fingolimod—Skin disorder—Docetaxel—breast cancer	7.2e-05	0.000456	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—breast cancer	7.16e-05	0.000454	CcSEcCtD
Fingolimod—Diarrhoea—Gemcitabine—breast cancer	7.14e-05	0.000452	CcSEcCtD
Fingolimod—Infection—Capecitabine—breast cancer	7.13e-05	0.000451	CcSEcCtD
Fingolimod—Dizziness—Irinotecan—breast cancer	7.09e-05	0.000449	CcSEcCtD
Fingolimod—Nervous system disorder—Capecitabine—breast cancer	7.04e-05	0.000446	CcSEcCtD
Fingolimod—Eye disorder—Methotrexate—breast cancer	7.02e-05	0.000445	CcSEcCtD
Fingolimod—Diarrhoea—Fluorouracil—breast cancer	7.02e-05	0.000445	CcSEcCtD
Fingolimod—Cardiac disorder—Methotrexate—breast cancer	6.98e-05	0.000442	CcSEcCtD
Fingolimod—Skin disorder—Capecitabine—breast cancer	6.97e-05	0.000441	CcSEcCtD
Fingolimod—Hypotension—Docetaxel—breast cancer	6.92e-05	0.000438	CcSEcCtD
Fingolimod—Connective tissue disorder—Epirubicin—breast cancer	6.91e-05	0.000438	CcSEcCtD
Fingolimod—Angiopathy—Methotrexate—breast cancer	6.82e-05	0.000432	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—breast cancer	6.8e-05	0.000431	CcSEcCtD
Fingolimod—Dizziness—Fluorouracil—breast cancer	6.79e-05	0.00043	CcSEcCtD
Fingolimod—Mediastinal disorder—Methotrexate—breast cancer	6.77e-05	0.000429	CcSEcCtD
Fingolimod—Headache—Mitoxantrone—breast cancer	6.71e-05	0.000425	CcSEcCtD
Fingolimod—Headache—Irinotecan—breast cancer	6.71e-05	0.000425	CcSEcCtD
Fingolimod—Hypotension—Capecitabine—breast cancer	6.7e-05	0.000425	CcSEcCtD
Fingolimod—Paraesthesia—Docetaxel—breast cancer	6.65e-05	0.000421	CcSEcCtD
Fingolimod—Alopecia—Methotrexate—breast cancer	6.64e-05	0.000421	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—breast cancer	6.63e-05	0.00042	CcSEcCtD
Fingolimod—Dyspnoea—Docetaxel—breast cancer	6.61e-05	0.000418	CcSEcCtD
Fingolimod—Mental disorder—Methotrexate—breast cancer	6.59e-05	0.000417	CcSEcCtD
Fingolimod—Eye disorder—Epirubicin—breast cancer	6.57e-05	0.000416	CcSEcCtD
Fingolimod—Headache—Gemcitabine—breast cancer	6.54e-05	0.000414	CcSEcCtD
Fingolimod—Cardiac disorder—Epirubicin—breast cancer	6.53e-05	0.000413	CcSEcCtD
Fingolimod—Paraesthesia—Capecitabine—breast cancer	6.44e-05	0.000408	CcSEcCtD
Fingolimod—Headache—Fluorouracil—breast cancer	6.43e-05	0.000407	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Docetaxel—breast cancer	6.4e-05	0.000405	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—breast cancer	6.4e-05	0.000405	CcSEcCtD
Fingolimod—Dyspnoea—Capecitabine—breast cancer	6.4e-05	0.000405	CcSEcCtD
Fingolimod—Fatigue—Docetaxel—breast cancer	6.39e-05	0.000405	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—breast cancer	6.38e-05	0.000404	CcSEcCtD
Fingolimod—Mediastinal disorder—Epirubicin—breast cancer	6.34e-05	0.000401	CcSEcCtD
Fingolimod—Back pain—Methotrexate—breast cancer	6.33e-05	0.000401	CcSEcCtD
Fingolimod—Asthenia—Paclitaxel—breast cancer	6.27e-05	0.000397	CcSEcCtD
Fingolimod—Alopecia—Epirubicin—breast cancer	6.22e-05	0.000394	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Capecitabine—breast cancer	6.19e-05	0.000392	CcSEcCtD
Fingolimod—Fatigue—Capecitabine—breast cancer	6.18e-05	0.000392	CcSEcCtD
Fingolimod—Pruritus—Paclitaxel—breast cancer	6.18e-05	0.000392	CcSEcCtD
Fingolimod—Vision blurred—Methotrexate—breast cancer	6.17e-05	0.000391	CcSEcCtD
Fingolimod—Mental disorder—Epirubicin—breast cancer	6.16e-05	0.00039	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—breast cancer	6.08e-05	0.000385	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—breast cancer	6.04e-05	0.000383	CcSEcCtD
Fingolimod—Diarrhoea—Paclitaxel—breast cancer	5.98e-05	0.000379	CcSEcCtD
Fingolimod—Back pain—Epirubicin—breast cancer	5.92e-05	0.000375	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—breast cancer	5.91e-05	0.000374	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—breast cancer	5.87e-05	0.000371	CcSEcCtD
Fingolimod—Leukopenia—Methotrexate—breast cancer	5.86e-05	0.000371	CcSEcCtD
Fingolimod—Dizziness—Paclitaxel—breast cancer	5.78e-05	0.000366	CcSEcCtD
Fingolimod—Vision blurred—Epirubicin—breast cancer	5.77e-05	0.000365	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—breast cancer	5.75e-05	0.000364	CcSEcCtD
Fingolimod—Cough—Methotrexate—breast cancer	5.71e-05	0.000362	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—breast cancer	5.7e-05	0.000361	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.53e-05	0.00035	CcSEcCtD
Fingolimod—Leukopenia—Epirubicin—breast cancer	5.48e-05	0.000347	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—breast cancer	5.48e-05	0.000347	CcSEcCtD
Fingolimod—Headache—Paclitaxel—breast cancer	5.48e-05	0.000347	CcSEcCtD
Fingolimod—Palpitations—Epirubicin—breast cancer	5.41e-05	0.000343	CcSEcCtD
Fingolimod—Cough—Epirubicin—breast cancer	5.34e-05	0.000338	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—breast cancer	5.34e-05	0.000338	CcSEcCtD
Fingolimod—Asthenia—Docetaxel—breast cancer	5.32e-05	0.000337	CcSEcCtD
Fingolimod—Infection—Methotrexate—breast cancer	5.31e-05	0.000336	CcSEcCtD
Fingolimod—Hypertension—Epirubicin—breast cancer	5.29e-05	0.000335	CcSEcCtD
Fingolimod—Pruritus—Docetaxel—breast cancer	5.24e-05	0.000332	CcSEcCtD
Fingolimod—Nervous system disorder—Methotrexate—breast cancer	5.24e-05	0.000332	CcSEcCtD
Fingolimod—Skin disorder—Methotrexate—breast cancer	5.19e-05	0.000328	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.18e-05	0.000328	CcSEcCtD
Fingolimod—Asthenia—Capecitabine—breast cancer	5.15e-05	0.000326	CcSEcCtD
Fingolimod—Pruritus—Capecitabine—breast cancer	5.08e-05	0.000321	CcSEcCtD
Fingolimod—Leukopenia—Doxorubicin—breast cancer	5.07e-05	0.000321	CcSEcCtD
Fingolimod—Diarrhoea—Docetaxel—breast cancer	5.07e-05	0.000321	CcSEcCtD
Fingolimod—Palpitations—Doxorubicin—breast cancer	5.01e-05	0.000317	CcSEcCtD
Fingolimod—Hypotension—Methotrexate—breast cancer	4.99e-05	0.000316	CcSEcCtD
Fingolimod—Infection—Epirubicin—breast cancer	4.96e-05	0.000314	CcSEcCtD
Fingolimod—Cough—Doxorubicin—breast cancer	4.94e-05	0.000313	CcSEcCtD
Fingolimod—Diarrhoea—Capecitabine—breast cancer	4.91e-05	0.000311	CcSEcCtD
Fingolimod—Nervous system disorder—Epirubicin—breast cancer	4.9e-05	0.00031	CcSEcCtD
Fingolimod—Dizziness—Docetaxel—breast cancer	4.9e-05	0.00031	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—breast cancer	4.89e-05	0.00031	CcSEcCtD
Fingolimod—Skin disorder—Epirubicin—breast cancer	4.85e-05	0.000307	CcSEcCtD
Fingolimod—Paraesthesia—Methotrexate—breast cancer	4.8e-05	0.000304	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.79e-05	0.000303	CcSEcCtD
Fingolimod—Dyspnoea—Methotrexate—breast cancer	4.76e-05	0.000302	CcSEcCtD
Fingolimod—Dizziness—Capecitabine—breast cancer	4.74e-05	0.0003	CcSEcCtD
Fingolimod—Hypotension—Epirubicin—breast cancer	4.67e-05	0.000296	CcSEcCtD
Fingolimod—Headache—Docetaxel—breast cancer	4.64e-05	0.000294	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Methotrexate—breast cancer	4.61e-05	0.000292	CcSEcCtD
Fingolimod—Fatigue—Methotrexate—breast cancer	4.6e-05	0.000292	CcSEcCtD
Fingolimod—Infection—Doxorubicin—breast cancer	4.59e-05	0.000291	CcSEcCtD
Fingolimod—Nervous system disorder—Doxorubicin—breast cancer	4.53e-05	0.000287	CcSEcCtD
Fingolimod—Headache—Capecitabine—breast cancer	4.49e-05	0.000285	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—breast cancer	4.49e-05	0.000284	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—breast cancer	4.49e-05	0.000284	CcSEcCtD
Fingolimod—Dyspnoea—Epirubicin—breast cancer	4.46e-05	0.000282	CcSEcCtD
Fingolimod—Hypotension—Doxorubicin—breast cancer	4.32e-05	0.000274	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—breast cancer	4.31e-05	0.000273	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—breast cancer	4.31e-05	0.000273	CcSEcCtD
Fingolimod—Paraesthesia—Doxorubicin—breast cancer	4.15e-05	0.000263	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—breast cancer	4.12e-05	0.000261	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Doxorubicin—breast cancer	3.99e-05	0.000253	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—breast cancer	3.99e-05	0.000252	CcSEcCtD
Fingolimod—Asthenia—Methotrexate—breast cancer	3.83e-05	0.000243	CcSEcCtD
Fingolimod—Pruritus—Methotrexate—breast cancer	3.78e-05	0.000239	CcSEcCtD
Fingolimod—Diarrhoea—Methotrexate—breast cancer	3.65e-05	0.000231	CcSEcCtD
Fingolimod—Asthenia—Epirubicin—breast cancer	3.59e-05	0.000227	CcSEcCtD
Fingolimod—Pruritus—Epirubicin—breast cancer	3.54e-05	0.000224	CcSEcCtD
Fingolimod—Dizziness—Methotrexate—breast cancer	3.53e-05	0.000224	CcSEcCtD
Fingolimod—Diarrhoea—Epirubicin—breast cancer	3.42e-05	0.000217	CcSEcCtD
Fingolimod—Headache—Methotrexate—breast cancer	3.35e-05	0.000212	CcSEcCtD
Fingolimod—Asthenia—Doxorubicin—breast cancer	3.32e-05	0.00021	CcSEcCtD
Fingolimod—Dizziness—Epirubicin—breast cancer	3.3e-05	0.000209	CcSEcCtD
Fingolimod—Pruritus—Doxorubicin—breast cancer	3.27e-05	0.000207	CcSEcCtD
Fingolimod—Diarrhoea—Doxorubicin—breast cancer	3.16e-05	0.0002	CcSEcCtD
Fingolimod—Headache—Epirubicin—breast cancer	3.13e-05	0.000198	CcSEcCtD
Fingolimod—Dizziness—Doxorubicin—breast cancer	3.06e-05	0.000194	CcSEcCtD
Fingolimod—Headache—Doxorubicin—breast cancer	2.9e-05	0.000183	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—MAPK3—breast cancer	5.31e-06	2.92e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—breast cancer	5.28e-06	2.9e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—breast cancer	5.28e-06	2.9e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPX2—breast cancer	5.27e-06	2.9e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA2—breast cancer	5.27e-06	2.9e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—breast cancer	5.24e-06	2.88e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CA—breast cancer	5.24e-06	2.88e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SULT1A1—breast cancer	5.2e-06	2.86e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPX4—breast cancer	5.2e-06	2.86e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ESRRA—breast cancer	5.2e-06	2.86e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ANGPTL4—breast cancer	5.2e-06	2.86e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—breast cancer	5.16e-06	2.84e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFB1—breast cancer	5.15e-06	2.83e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SYNJ2—breast cancer	5.13e-06	2.82e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—IDH1—breast cancer	5.08e-06	2.79e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA1—breast cancer	5.08e-06	2.79e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—breast cancer	5.05e-06	2.78e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—breast cancer	5.05e-06	2.77e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—breast cancer	5.05e-06	2.77e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NAT2—breast cancer	5.02e-06	2.76e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—breast cancer	5.02e-06	2.76e-05	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—breast cancer	4.98e-06	2.74e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—breast cancer	4.95e-06	2.72e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HADHB—breast cancer	4.93e-06	2.71e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPI—breast cancer	4.93e-06	2.71e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—breast cancer	4.83e-06	2.66e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—breast cancer	4.83e-06	2.66e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—breast cancer	4.79e-06	2.63e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NDUFS3—breast cancer	4.77e-06	2.62e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—breast cancer	4.77e-06	2.62e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDH7A1—breast cancer	4.7e-06	2.59e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDH1A1—breast cancer	4.7e-06	2.59e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—breast cancer	4.63e-06	2.55e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—breast cancer	4.58e-06	2.52e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ADSL—breast cancer	4.51e-06	2.48e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FHL2—breast cancer	4.51e-06	2.48e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NME1—breast cancer	4.51e-06	2.48e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PHGDH—breast cancer	4.51e-06	2.48e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—UMPS—breast cancer	4.51e-06	2.48e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CHST9—breast cancer	4.49e-06	2.47e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—breast cancer	4.46e-06	2.45e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—breast cancer	4.46e-06	2.45e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—BRIP1—breast cancer	4.42e-06	2.43e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LDHB—breast cancer	4.42e-06	2.43e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HPSE—breast cancer	4.42e-06	2.43e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MED12—breast cancer	4.41e-06	2.42e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—DPYD—breast cancer	4.41e-06	2.42e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—breast cancer	4.39e-06	2.41e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—breast cancer	4.38e-06	2.41e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALDOA—breast cancer	4.34e-06	2.38e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—breast cancer	4.28e-06	2.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—COX11—breast cancer	4.25e-06	2.34e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—breast cancer	4.24e-06	2.33e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NCOA3—breast cancer	4.21e-06	2.31e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCC1—breast cancer	4.19e-06	2.31e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HMMR—breast cancer	4.19e-06	2.31e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA3—breast cancer	4.19e-06	2.31e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC2A2—breast cancer	4.18e-06	2.3e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCG2—breast cancer	4.1e-06	2.25e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CPT1A—breast cancer	4.1e-06	2.25e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTR—breast cancer	4.1e-06	2.25e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARGC1B—breast cancer	4.06e-06	2.23e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—breast cancer	4.06e-06	2.23e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—breast cancer	4.05e-06	2.22e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HPGDS—breast cancer	4.02e-06	2.21e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HBA1—breast cancer	3.99e-06	2.19e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTT1—breast cancer	3.9e-06	2.14e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ACHE—breast cancer	3.9e-06	2.14e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SHMT1—breast cancer	3.89e-06	2.14e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CDA—breast cancer	3.89e-06	2.14e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—breast cancer	3.88e-06	2.13e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA9—breast cancer	3.83e-06	2.11e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA4—breast cancer	3.83e-06	2.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLCO1B1—breast cancer	3.74e-06	2.06e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC2A5—breast cancer	3.74e-06	2.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA2—breast cancer	3.74e-06	2.05e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPX2—breast cancer	3.74e-06	2.05e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPX4—breast cancer	3.69e-06	2.03e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SULT1A1—breast cancer	3.69e-06	2.03e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP17A1—breast cancer	3.69e-06	2.03e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ENO1—breast cancer	3.65e-06	2.01e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS1—breast cancer	3.65e-06	2.01e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APRT—breast cancer	3.62e-06	1.99e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA1—breast cancer	3.61e-06	1.98e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—IDH1—breast cancer	3.61e-06	1.98e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—breast cancer	3.58e-06	1.97e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP2D6—breast cancer	3.58e-06	1.97e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NAT2—breast cancer	3.56e-06	1.96e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NCOA2—breast cancer	3.51e-06	1.93e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—FASN—breast cancer	3.41e-06	1.87e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ESRRA—breast cancer	3.4e-06	1.87e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ANGPTL4—breast cancer	3.4e-06	1.87e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—BCHE—breast cancer	3.39e-06	1.87e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC5A5—breast cancer	3.35e-06	1.84e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NQO1—breast cancer	3.24e-06	1.78e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC2A1—breast cancer	3.24e-06	1.78e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPI—breast cancer	3.22e-06	1.77e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HADHB—breast cancer	3.22e-06	1.77e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP3A4—breast cancer	3.16e-06	1.74e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—DPYD—breast cancer	3.13e-06	1.72e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MED12—breast cancer	3.13e-06	1.72e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1B1—breast cancer	3.1e-06	1.71e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDOA—breast cancer	3.08e-06	1.69e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.08e-06	1.69e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.08e-06	1.69e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HSP90AA1—breast cancer	3.04e-06	1.67e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NCOA3—breast cancer	2.99e-06	1.64e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC2A2—breast cancer	2.97e-06	1.63e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NCOA1—breast cancer	2.96e-06	1.63e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADSL—breast cancer	2.95e-06	1.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PHGDH—breast cancer	2.95e-06	1.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FHL2—breast cancer	2.95e-06	1.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UMPS—breast cancer	2.95e-06	1.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NME1—breast cancer	2.95e-06	1.62e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP19A1—breast cancer	2.92e-06	1.6e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—STK11—breast cancer	2.92e-06	1.6e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CPT1A—breast cancer	2.91e-06	1.6e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCG2—breast cancer	2.91e-06	1.6e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTR—breast cancer	2.91e-06	1.6e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LDHB—breast cancer	2.89e-06	1.59e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—BRIP1—breast cancer	2.89e-06	1.59e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HPSE—breast cancer	2.89e-06	1.59e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HPGDS—breast cancer	2.85e-06	1.57e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HBA1—breast cancer	2.83e-06	1.56e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTT1—breast cancer	2.76e-06	1.52e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ACHE—breast cancer	2.76e-06	1.52e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HMMR—breast cancer	2.74e-06	1.51e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCC1—breast cancer	2.74e-06	1.51e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA3—breast cancer	2.74e-06	1.51e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—COMT—breast cancer	2.71e-06	1.49e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTP1—breast cancer	2.7e-06	1.48e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HMOX1—breast cancer	2.66e-06	1.46e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ITPR1—breast cancer	2.66e-06	1.46e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARGC1B—breast cancer	2.65e-06	1.46e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP17A1—breast cancer	2.62e-06	1.44e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS1—breast cancer	2.59e-06	1.42e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENO1—breast cancer	2.59e-06	1.42e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCB1—breast cancer	2.56e-06	1.41e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMS—breast cancer	2.51e-06	1.38e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA9—breast cancer	2.51e-06	1.38e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA4—breast cancer	2.51e-06	1.38e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NCOA2—breast cancer	2.49e-06	1.37e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLA2G4A—breast cancer	2.48e-06	1.36e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NCOR1—breast cancer	2.48e-06	1.36e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—breast cancer	2.48e-06	1.36e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA2—breast cancer	2.44e-06	1.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPX2—breast cancer	2.44e-06	1.34e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FASN—breast cancer	2.42e-06	1.33e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SULT1A1—breast cancer	2.41e-06	1.33e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPX4—breast cancer	2.41e-06	1.33e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—BCHE—breast cancer	2.41e-06	1.32e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC5A5—breast cancer	2.38e-06	1.31e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPX1—breast cancer	2.38e-06	1.31e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—IDH1—breast cancer	2.36e-06	1.3e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA1—breast cancer	2.36e-06	1.3e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1A1—breast cancer	2.35e-06	1.29e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ERCC2—breast cancer	2.33e-06	1.28e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NAT2—breast cancer	2.33e-06	1.28e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC2A1—breast cancer	2.3e-06	1.26e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NQO1—breast cancer	2.3e-06	1.26e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP3A4—breast cancer	2.24e-06	1.23e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1B1—breast cancer	2.2e-06	1.21e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—breast cancer	2.19e-06	1.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.16e-06	1.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NCOA1—breast cancer	2.1e-06	1.16e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—STK11—breast cancer	2.07e-06	1.14e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP19A1—breast cancer	2.07e-06	1.14e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—DPYD—breast cancer	2.04e-06	1.12e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MED12—breast cancer	2.04e-06	1.12e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CAV1—breast cancer	2.02e-06	1.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDOA—breast cancer	2.01e-06	1.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NCOA3—breast cancer	1.95e-06	1.07e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC2A2—breast cancer	1.94e-06	1.07e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—COMT—breast cancer	1.93e-06	1.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTP1—breast cancer	1.92e-06	1.05e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCG2—breast cancer	1.9e-06	1.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTR—breast cancer	1.9e-06	1.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CPT1A—breast cancer	1.9e-06	1.04e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HMOX1—breast cancer	1.89e-06	1.04e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ITPR1—breast cancer	1.89e-06	1.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HPGDS—breast cancer	1.86e-06	1.02e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HBA1—breast cancer	1.85e-06	1.02e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CG—breast cancer	1.84e-06	1.01e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCB1—breast cancer	1.81e-06	9.97e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTT1—breast cancer	1.81e-06	9.94e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ACHE—breast cancer	1.81e-06	9.94e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMS—breast cancer	1.78e-06	9.79e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.76e-06	9.68e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NCOR1—breast cancer	1.76e-06	9.68e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—breast cancer	1.76e-06	9.68e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP17A1—breast cancer	1.71e-06	9.41e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS1—breast cancer	1.69e-06	9.31e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENO1—breast cancer	1.69e-06	9.31e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPX1—breast cancer	1.69e-06	9.27e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1A1—breast cancer	1.67e-06	9.18e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2D6—breast cancer	1.66e-06	9.13e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ERCC2—breast cancer	1.66e-06	9.1e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NCOA2—breast cancer	1.63e-06	8.96e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CD—breast cancer	1.62e-06	8.91e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALB—breast cancer	1.6e-06	8.79e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FASN—breast cancer	1.58e-06	8.69e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—BCHE—breast cancer	1.57e-06	8.66e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—breast cancer	1.56e-06	8.56e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC5A5—breast cancer	1.56e-06	8.55e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NOS3—breast cancer	1.53e-06	8.41e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NQO1—breast cancer	1.5e-06	8.26e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC2A1—breast cancer	1.5e-06	8.26e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1B1—breast cancer	1.44e-06	7.92e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CAV1—breast cancer	1.44e-06	7.89e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.41e-06	7.76e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CB—breast cancer	1.41e-06	7.76e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—breast cancer	1.4e-06	7.69e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NCOA1—breast cancer	1.37e-06	7.55e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP19A1—breast cancer	1.35e-06	7.44e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—STK11—breast cancer	1.35e-06	7.44e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CG—breast cancer	1.31e-06	7.19e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—COMT—breast cancer	1.26e-06	6.92e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTP1—breast cancer	1.25e-06	6.89e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HMOX1—breast cancer	1.24e-06	6.79e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ITPR1—breast cancer	1.23e-06	6.78e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTEN—breast cancer	1.22e-06	6.71e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCB1—breast cancer	1.19e-06	6.52e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMS—breast cancer	1.16e-06	6.4e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—breast cancer	1.15e-06	6.33e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.15e-06	6.33e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NCOR1—breast cancer	1.15e-06	6.33e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CD—breast cancer	1.15e-06	6.32e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALB—breast cancer	1.13e-06	6.24e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPX1—breast cancer	1.1e-06	6.06e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1A1—breast cancer	1.09e-06	6e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NOS3—breast cancer	1.09e-06	5.97e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ERCC2—breast cancer	1.08e-06	5.95e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—breast cancer	1.02e-06	5.59e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CB—breast cancer	1e-06	5.51e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—breast cancer	9.93e-07	5.46e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CAV1—breast cancer	9.38e-07	5.16e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTEN—breast cancer	8.66e-07	4.76e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—breast cancer	8.61e-07	4.73e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CG—breast cancer	8.55e-07	4.7e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CD—breast cancer	7.51e-07	4.13e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALB—breast cancer	7.42e-07	4.08e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NOS3—breast cancer	7.1e-07	3.9e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—breast cancer	7.03e-07	3.87e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CB—breast cancer	6.55e-07	3.6e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—breast cancer	6.49e-07	3.57e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—breast cancer	6.11e-07	3.36e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTEN—breast cancer	5.66e-07	3.11e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—breast cancer	4.99e-07	2.74e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—breast cancer	3.99e-07	2.2e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—breast cancer	3.26e-07	1.79e-06	CbGpPWpGaD
